Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-536
Closed -$78.4K 1475
2025
Q3
$78.4K Buy
536
+24
+5% +$3.63K 0.03% 192
2025
Q2
$79.9K Sell
512
-79
-13% -$12.5K 0.03% 177
2025
Q1
$97.3K Buy
591
+17
+3% +$2.83K 0.04% 145
2024
Q4
$93.4K Sell
574
-75
-12% -$13.4K 0.04% 147
2024
Q3
$127K Sell
649
-21
-3% -$3.87K 0.06% 128
2024
Q2
$116K Buy
670
+2
+0.3% +$333 0.06% 133
2024
Q1
$113K Buy
668
+267
+67% +$50K 0.06% 137
2023
Q4
$79.2K Buy
401
+269
+204% +$47.6K 0.06% 121
2023
Q3
$22.9K Buy
132
+84
+175% +$15.3K 0.02% 219
2023
Q2
$8.35K Sell
48
-5
-9% -$864 0.01% 361
2023
Q1
$8.88K Hold
53
0.01% 380
2022
Q4
$7.8K Sell
53
-200
-79% -$29.6K 0.01% 387
2022
Q3
$38K Buy
253
+200
+377% +$33.4K 0.03% 180
2022
Q2
$9K Buy
+53
New +$9.17K 0.01% 362

Other funds holding ZTS

Rise Advisors's ZTS Position: Q4 2025 in Review

Rise Advisors sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 536 shares — an estimated $78.4K sold.

Rise Advisors first reported a position in ZTS in Q2 2022 and held it in 14 quarters. The position peaked at $127K in Q3 2024. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Rise Advisors reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 536 Zoetis shares in Q4 2025, an estimated $78.4K.
  • Rise Advisors first reported a position in Zoetis in Q2 2022 and held it in 14 quarters.
  • Rise Advisors's Zoetis position peaked at $127K in Q3 2024.
  • 1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.